HONG KONG, August 2019 — As a medical emergency caused by severe cardiovascular diseases, myocardial infarction (MI) can inflict permanent and life-threatening damage to the heart.
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
San Diego, CA (US), August 2019 — Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery.
WINSTON-SALEM, NC (US), August 2019 – Prostate cancer is the most common cancer in men, with radical prostatectomy as a commonly chosen course of action. The reported rate of erectile dysfunction after prostate surgery for cancer is reportedly as high as 90 percent.
TOKYO (JP), August 2019 — The human liver is a vital organ involved in multiple functions.
SEATTLE, WA (US), August 2019 — Researchers at Fred Hutchinson Cancer Research Center have used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed with several blood disorders, including sickle cell disease and beta-thalassemia.
YOKOHAMA (JP), August 2019 — Scientists have developed an efficient method of successfully generating hair growth in nude mice.
LONDON (UK), August 2019 — A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research published in
CHICAGO, IL (US), July 2-19 — Researchers have discovered how the genetic defect in fragile X syndrome — a type of autism — delays production of neurons (nerve cells) at a critical time in the embryo's brain development.
OAKLAND, CA (US), July 2019 — The California Institute for Regenerative Medicine (CIRM) board has approved investing $19.7 million in four awards in its Translational Research program, which helps promising projects complete the testing needed to begin talking to the US Food and
STANFORD, CA (US), July 2019 — Researchers have uncovered how a genetic mutation contributes to a heart disease known as familial dilated cardiomyopathy. Existing drugs correct the defect in heart cells grown in a petri dish, suggesting a new therapeutic target.